TORL-1-23

· TORL Biotherapeutics, LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TORL-1-23, covering 2025-12-23 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Study of TORL-1-23 in Participants With Advanced Cancer [Phase 1]